ETFsXtrackers MSCI Europe Materials UCITS ETF 1C
Xtrackers
Xtrackers MSCI Europe Materials UCITS ETF 1C
DXSC XETRAAccumulatingLuxembourg
Last close · EUR
178.08EUR
-0.69% · -€1.24
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
DXSCBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +10.7%
- Sharpe 3Y
- 0.44
- Volatility 1Y
- 17.2%annualised
- Holdings
- 27Fund holdings
Performance
Compare
- DXSC+10.7%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| DXSC | -0.3% | +0.4% | +4.5% | +7.5% | +10.7% | +33.3% | +25.6% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.0% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | -0.8% | -4.5% | -6.3% | -8.5% | -5.1% | -42.2% | -45.7% |
Risk and return
Sharpe ratio · 3Y
0.44
Below MSCI World · 1.24- Return p.a.
- +8.6%
- Volatility
- 15.2%
- Max loss
- -17.5%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
DXSC
0.44
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 75.8%
- Holdings
- 27
- As of
- 1LAIR LIQUIDE SOCIETE ANONYME POURFR000012007317.22%
- 2RIO TINTOGB000718875711.94%
- 3GLENCORE PLCJE00B4T3BW648.96%
- 4ANGLO AMERICAN PLCGB00BTK05J607.21%
- 5BASF NDE000BASF1117.12%
- 6GIVAUDAN SACH00106459326.11%
- 7HOLCIM LTD AGCH00122140595.86%
- 8SIKA AGCH04187929224.55%
- 9ARCELORMITTAL SALU15987576873.50%
- 10NOVOZYMES CLASS BDK00603360143.33%
Countries
Classified 100.0%
Australia20.9%
Switzerland20.2%
France17.2%
DE
GB
LU
DK
SE
FI
CL
NL
NO
- Largest
- 20.9%Australia
- Top 3
- 58.3%
- Effective number
- 6.91 / HHI
Market cap
Weight vs holdings
75.8%of the fund sits in the top 10 holdings
75.8%24.1%
WeightHoldings
1017
- Holdings 1-10
- Holdings 11-27
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
